Non-invasive brain monitor company Cerebrotech Medical Systems said it won CE Mark approval for its intracranial fluids monitor.
The technology, developed at the University of California at Berkeley, detects changes in electrical proprties of tissues as a result of small changes in fluid, according to the Pleasanton, Calif.-based company’s site.
“We are very pleased to receive this validation of our technology. With clearance to commercialize in Europe, the company is moving into the next stage of its mission to significantly improve the clinical pathway and standard of care for patients with brain injuries,” said Mitch Levinson, the company’s co-founder and CEO.
The intracranial fluid monitor is meant for the early detection of dangerous cerebral events after stroke, brain injury, surgery or other conditions, CerebroTech said.
“It has been remarkable to watch this powerful technology unfold, and to see it realizing the potential that we were only imagining just a few years ago. Cerebrotech’s monitor can give us valuable insight into the progression of edema and bleeding in our patients, and help us manage their care as they recover from stroke and brain trauma,” Cerebrotech scientific advisory board chair Dr. Wade Smith said in a press release.
